Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 10 Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Skin Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Head and Neck Neoplasms 5 Urinary Bladder Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Merkel Cell 4 Breast Neoplasms 4 Sarcoma 3 Pancreatic Neoplasms 3 Mycosis Fungoides 3 Carcinoma, Squamous Cell 3 Carcinoma, Hepatocellular 3 Carcinoma, Basal Cell 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Rectal Neoplasms 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2

Interventions

Mitotane 7 Cisplatin 6 pembrolizumab 5 Etoposide 3 Doxorubicin 3 camrelizumab 2 apatinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cytoreduction Surgical Procedures 2 sodium thiosulfate 1 iodophenyl metomidate 1 fludarabine phosphate 1 dostarlimab 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Suramin 1 Sunitinib 1 Streptozocin 1 Sorafenib 1 Radiation 1 Paclitaxel 1 Observation 1 Nivolumab 1 Megestrol Acetate 1 Lymph Node Excision 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adrenocortical Carcinoma × cemiplimab × Clear all

NCT07085572 2025-10-06

INTERVAL

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡